CCO Oncology Podcast
En podkast av Clinical Care Options
Kategorier:
189 Episoder
-
Treatment Options for Patients With Multiple Myeloma After First Relapse
Publisert: 14.7.2021 -
Precision Medicine in Gynecologic Cancers: Expert Answers to Your Questions
Publisert: 12.7.2021 -
Expert Answers to Questions on Managing Neurofibromatosis Type 1 and MEK Inhibitors for NF1-Associated Plexiform Neurofibromas
Publisert: 12.7.2021 -
Expert Answers to Questions on PARP Inhibitor Combinations in Prostate Cancer
Publisert: 30.6.2021 -
Immunotherapy for Advanced HCC: Current Options and Expert Answers to Clinician Questions
Publisert: 29.6.2021 -
Expert Insight on Key Data From ASCO 2021 Informing Treatment for Endometrial, Ovarian, and Cervical Cancer
Publisert: 24.6.2021 -
Optimizing Therapy for Relapsed/Refractory Multiple Myeloma: Expert Answers to Your Questions
Publisert: 17.6.2021 -
Experts Answer FAQs on Biomarker-Driven Therapy for Non-Small-Cell Lung Cancer
Publisert: 19.5.2021 -
Congress to Clinic: Post-ELCC Updates on Antibody–Drug Conjugates in NSCLC
Publisert: 18.5.2021 -
Immunotherapy for Advanced HCC: Case Series
Publisert: 17.5.2021 -
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Germany
Publisert: 13.5.2021 -
Managing Toxicities Associated With FGFR Inhibitors in Urothelial Cancer and Beyond
Publisert: 4.5.2021 -
Optimizing the Timing and Sequencing of Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer
Publisert: 28.4.2021 -
Expert Answers to Questions on Contemporary Management of Multiple Myeloma
Publisert: 22.4.2021 -
Combining PARP inhibitors With Other Treatments for Men With Prostate Cancer: Clinical Trial Updates
Publisert: 19.4.2021 -
Rationale for Combining PARP Inhibitors With Other Therapies in Prostate Cancer
Publisert: 15.4.2021 -
Expert Insight on Key Data From SGO 2021 Informing Treatment for Endometrial and Ovarian Cancer
Publisert: 6.4.2021 -
Expert Answers to Questions on PARP Inhibition for Prostate Cancer
Publisert: 6.4.2021 -
Expert Insights on Highlights From ASH 2020 on Lymphomas/CLL
Publisert: 26.3.2021 -
Improving Outcomes in EGFR-Mutated Non-Small-Cell Lung Cancer: Global Insights on Evolving Practice Standards
Publisert: 25.3.2021
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
